Steven Rodriguez
Acute Care · Olympia, WANPI 1528432135
Payments from drug & device makers
What this record shows
13 manufacturers reported payments, led by Terumo Cardiovascular Systems Corporation at 32.9% of the total. Among acute care clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 51 payments — averaging $59.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Terumo Cardiovascular Systems Corporation$1K
- Medical Device Business Services, Inc.$895
- Alnylam Pharmaceuticals Inc.$293
- Impulse Dynamics (USA) Inc.$180
- AstraZeneca$148
- Actelion Pharmaceuticals US, Inc.$118
- plus $415 from 7 others
What the payments were for
- Travel & lodging$1,59352%
- Food & beverage$1,45948%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Terumo Cardiovascular Systems Corporation | 4 | $1,004 |
| Medical Device Business Services, Inc. | 7 | $895 |
| Alnylam Pharmaceuticals Inc. | 11 | $293 |
| Impulse Dynamics (USA) Inc. | 8 | $180 |
| AstraZeneca(2 entities) | 3 | $148 |
| Actelion Pharmaceuticals US, Inc. | 1 | $118 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $100 |
| Merck | 6 | $98 |
| Novartis | 5 | $81 |
| Davol Inc. | 1 | $70 |
| Abbott | 1 | $25 |
| BD | 1 | $23 |
| Bayer | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,052 in reported general payments places this provider in the 90th percentile of 135 acute care providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 54 | $455 |
| Ondansetron OdtOndansetron | 36 | $413 |
| Atorvastatin Calcium | 32 | $270 |
| Oxycodone Hcl | 46 | $227 |
| Metoprolol Succinate | 15 | $173 |
| Gabapentin | 21 | $157 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 26 | $132 |
| Methocarbamol | 21 | $120 |
| Amiodarone Hcl | 32 | $112 |
| Metoprolol Tartrate | 26 | $48 |
| Potassium Chloride | 18 | $42 |
| Furosemide | 34 | $31 |
Paid to pharmacies, not to this prescriber.
Other acute care in Olympia
- Jessica MaikeOlympia$430
- Jennifer HartleySeattle$121K
- Elizabeth PerpetuaSeattle$112K
- Leslie CasiasSeattle$60K
- Joelle FathiSeattle$22K
- Sirithepphavanh OliverSeattle$19K
- John KingWenatchee$7K
- Desiree WoodSeattle$4K
- Nellie GoodinTacoma$3K
- Anita LoehmerFederal Way$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.